FDA Adverse Event Malfunction Summary report: N

PRECISION XTRA

MDR report key: 1972026 · Received January 27, 2011

Report

Report Number
2954323-2011-01218
Event Type
Malfunction
Date Received
January 27, 2011
Date of Event
December 27, 2010
Report Date
January 27, 2011
Product Code
NBW
Removal / Correction Number
ADC FA1197-2010
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

RETAIN SAMPLES OF PRECISION TEST STRIP LOTS MANUFACTURED WITH HOT-MELT GLUE BATCHES EXHIBITED LOWER THAN EXPECTED READINGS ON CONTINUOUS STORAGE AFTER NINE MONTHS AT 30 DEGREES CELSIUS DURING ROUTINE STABILITY PERFORMANCE TESTING. THIS STABILITY ISSUE COULD LEAD TO THE GENERATION OF INCORRECTLY DEPRESSED BLOOD GLUCOSE RESULTS AND THESE ERRONEOUS RESULTS MAY BE IN THE "C", "D" OR "E" ZONES OF PARKES ERROR GRID, AND AS SUCH, HAVE THE POTENTIAL TO BE CLINICALLY SIGNIFICANT. THE PRIMARY CAUSE HAS BEEN IDENTIFIED TO BE BATCH TO BATCH GLUE VARIABILITY. THE FDA HAS BEEN INFORMED OF THE FIELD ACTION PER 21CFR806 (FIELD ACTION REFERENCE NUMBER 2954323-12/22/10-001-R). ALL AFFECTED CONSIGNEES WERE NOTIFIED BY LETTER BEGINNING DECEMBER 22, 2010.

Description of Event or Problem · 1

CUSTOMER'S MOTHER REPORTED CUSTOMER RECEIVED READINGS OF 70 MG/DL ON (B)(6) 2010 AND 69 MG/DL ON (B)(6) 2010, WHICH WERE LOWER THAN HE FELT. SHE FURTHER REPORTED HE SUBSEQUENTLY EXPERIENCED TREMULOUSNESS, HEADACHES AND HUNGER. NO THIRD-PARTY EMERGENT INTERVENTION WAS REPORTED. CUSTOMER SELF-TREATED BY DRINKING JUICE AND EATING CRACKERS. IT WAS ADDITIONALLY REPORTED THE CUSTOMER HAD BEEN USING TEST STRIPS RELATED TO AN ON-GOING FIELD ACTION FOR ABBOTT'S PRECISION FAMILY TEST STRIPS. THE READINGS THE CUSTOMER RECEIVED ARE CONSISTENT WITH THE SYMPTOMS EXPERIENCED. THERE WAS NO REPORT OF DEATH, SERIOUS INJURY OR MISTREATMENT ASSOCIATED WITH THIS COMPLAINT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 PRECISION XTRA BLOOD GLUCOSE MONITORING SYSTEM NBW 45001A798

Patients

Seq Age Sex Outcome Treatment
1